Investigating the feasibility of a new AI driven innovation that support self-management of mental wellbeing

心理健康包括我们的情感、心理和社会健康。它会影响我们的思维、感觉和行为。它还有助于决定我们如何应对压力、与他人相处，以及做出健康的选择。然而，随着COVID、乌克兰战争和日益严重的经济衰退的影响，NHS已经无法应对的心理健康危机日益严重，导致不可持续的积压。我们独特的环形触发设备提供了我们的专利治疗--主动生物反馈，通过12个生理、行为和环境传感器进行个性化。这种疗法使用通过生物反馈系统个性化的光、声和触觉提示，帮助人们放松、放松和分散焦虑的注意力。每四个成年人中就有一个在一年中至少经历过一次可诊断的心理健康问题。在英国，心理健康问题是导致残疾的最大原因。据估计，每年的经济成本为1050亿GB--大致相当于整个NHS的成本。到2027年，焦虑症市场规模预计将达到130.3亿美元，压力管理市场预计将达到206亿美元。由于经济低迷、大宗商品成本上升和全球投资减少，我们需要资金来对用户对创新的接受程度进行可行性研究，以支持心理健康的自我管理。目前的经济环境意味着这个项目有很高的风险，目前人们对此兴趣不大。然而，全球迫切需要支持患有精神健康问题的患者。这笔赠款资金将使企业能够在精神健康问题上升的时候加快压力和焦虑产品的开发--这是因为需要公共资金的确切原因。

Mental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act. It also helps determine how we handle stress, relate to others, and make healthy choices.However, with the impact of COVID, war in Ukraine and growing economic downturn there is a growing mental health crisis which the NHS was already unable to cope with, leading to an unsustainable backlog.Our unique ring trigger device delivers our patented treatment, Active-Biofeedback, personalised by the 12 physiological, behavioural and environmental sensors. The therapy uses light, sound and tactile cues personalised through a biofeedback system to help people relax, unwind and distract from their anxieties.One in four adults' experiences at least one diagnosable mental health problem in any given year. Mental health problems represent the largest single cause of disability in the UK. The cost to the economy is estimated at £105 billion a year -- roughly the cost of the entire NHS. Anxiety Disorder market size is projected to reach $13.03bn by 2027 and stress management market is expected to reach $20.6bn by 2024\.We require funding to conduct feasibility research into the user acceptance of the innovation to support self-management of mental wellbeing due to economic downturn, rising commodity costs and reduction in global investment. The current economic climate means that there is a high risk associated with this project which there is little appetite for at this time.However, there is an urgent global clinical need to support patient suffering from mental health issues. This grant funding will allow the business to accelerate development of the stress and anxiety product at a time when mental health issues are rising - due to the exact reason why public funding is needed.